Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

September 4, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG

SHR-1905 Injection

DRUG

SHR-1905 Placebo Injection

Trial Locations (1)

Eye & Ent Hospital of Fudan University, Shanghai

All Listed Sponsors

lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY

NCT05891483 - Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps | Biotech Hunter | Biotech Hunter